Effect of buccal dexmedetomidine premedication on minimum alveolar concentration of sevoflurane for successful insertion of laryngeal mask airway in children

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPD-17011615

Enrollment

Unknown

Registered

2017-06-10

Start date

2017-06-01

Completion date

Unknown

Last updated

2017-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic inguinal herniorhaphy or Penile plastic Surgery

Interventions

Group D2:buccal dexmedetomidine 2µg/kg

Group D4:buccal dexmedetomidine 4µg/kg

Eligibility

Sex/Gender

All

Age

2 Years to 6 Years

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) physical status I, aged 2–6 years old, BMI 18-25 kg/m2, scheduled to undergo laparoscopic inguinal herniorhaphy or Penile plastic Surgery

Exclusion criteria

Exclusion criteria: Patients with anticipated difficult airway,bronchial asthma, current upper respiratory tract infections in 2 weeks, allergy or hypersensitive reaction to dexmedetomidine, known cardiac arrhythmia or congenital heart disease, mental diseases, or other congenital and neurologic.al diseases were excluded from the study

Design outcomes

Primary

Measure	Time frame
The response of patients to the insertion of the laryngeal mask;	—

Secondary

Measure	Time frame
Sedation score of parenta;face mask acceptance score;	—

Countries

China

Contacts

Public ContactHongxin Ji

Longguang Distict People's Hospital of Shenzhen

hongxinji@163.com+86 0755-28932833-6306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026